Thyroid Eye Disease as Initial Manifestation of Graves' Disease Following Viral Vector SARS-CoV-2 Vaccine: Report of a Case and Review of the Literature.

Armeni, Anastasia K; Markantes, Georgios &#922;; Stathopoulou, Alexandra; Saltiki, Katerina; Zampakis, Petros; Assimakopoulos, Stelios F; Michalaki, Marina A

Armeni, Anastasia K; Markantes, Georgios Κ; Stathopoulou, Alexandra; Saltiki, Katerina; Zampakis, Petros; Assimakopoulos, Stelios F; Michalaki, Marina A.

Afiliação

Armeni AK; Division of Endocrinology-Department of Internal Medicine, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Markantes GΚ; Division of Endocrinology-Department of Internal Medicine, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Stathopoulou A; Division of Endocrinology-Department of Internal Medicine, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Saltiki K; Endocrine Unit, Department of Clinical Therapeutics, National and Kapodistrian University, 11528 Athens, Greece.
Zampakis P; Department of Radiology, University Hospital of Patras, 26504 Patras, Greece.
Assimakopoulos SF; Division of Infectious Diseases-Department of Internal Medicine, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Michalaki MA; Division of Endocrinology-Department of Internal Medicine, School of Health Sciences, University of Patras, 26504 Patras, Greece.

Vaccines (Basel) ; 11(10)2023 Oct 10.

Article em En | MEDLINE | ID: mdl-37896977

Palavras-chave

COVID-19; ChAdox1nCoV-19; Graves' disease; thyroid eye disease; viral vector SARS-CoV-2 vaccine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google